| [1] |
Wang D, Ouyang J, Zhou P, et al. A Novel Low-Cost Wireless Footwear System for Monitoring Diabetic Foot Patients[J]. IEEE Trans Biomed Circuits Syst, 2021, 15(1): 43-54.
|
| [2] |
Abbas ZG, Boulton AJM. Diabetic foot ulcer disease in African continent: 'From clinical care to implementation’- Review of diabetic foot in last 60 years - 1960 to 2020[J]. Diabetes Res Clin Pract, 2022, 183: 109155.
|
| [3] |
Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger)[J]. Ann Med, 2017, 49(2): 106-116.
|
| [4] |
Fu XL, Ding H, Miao WW, et al. Global recurrence rates in diabetic foot ulcers: A systematic review and meta-analysis[J]. Diabetes Metab Res Rev, 2019, 35(6): e3160.
|
| [5] |
郭光华，朱峰，闵定宏，等. 糖尿病足合并难愈性创面外科治疗全国专家共识(2020版)[J/CD]. 中华损伤与修复杂志(电子版), 2020, 15(4): 256-263.
|
| [6] |
Mader JK, Haas W, Aberer F, et al. Patients with healed diabetic foot ulcer represent a cohort at highest risk for future fatal events[J]. Sci Rep, 2019, 9(1): 10325.
|
| [7] |
Vadiveloo T, Jeffcoate W, Donnan PT, et al. Amputation-free survival in 17，353 people at high risk for foot ulceration in diabetes: a national observational study[J]. Diabetologia, 2018, 61(12): 2590-2597.
|
| [8] |
李炳辉，籍胤玺. 糖尿病足创面的治疗策略[J/CD]. 中华损伤与修复杂志(电子版), 2009, 4(4): 375-383.
|
| [9] |
Jiang Y, Ran X, Jia L, et al. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China[J]. Int J Low Extrem Wounds, 2015, 14(1): 19-27.
|
| [10] |
Yamagishi S, Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy[J]. Curr Pharm Des, 2005, 11(18): 2279-2299.
|
| [11] |
李炳辉，陈洪平. 糖尿病足创面局部处理[J/CD]. 中华损伤与修复杂志(电子版), 2011, 6(4): 516-521.
|
| [12] |
Spiliopoulos S, Festas G, Paraskevopoulos I, et al. Overcoming ischemia in the diabetic foot: Minimally invasive treatment options[J]. World J Diabetes, 2021, 12(12): 2011-2026.
|
| [13] |
Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association[J]. Diabetes Care, 2017, 40(1): 136-154.
|
| [14] |
Feldman EL, Nave KA, Jensen TS, et al. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain[J]. Neuron, 2017, 93(6): 1296-1313.
|
| [15] |
Sajic M. Mitochondrial dynamics in peripheral neuropathies[J]. Antioxid Redox Signal, 2014, 21(4): 601-620.
|
| [16] |
武钰翔，姜玉峰，王爱红，等. 糖尿病足局部抗感染治疗的研究进展[J]. 临床荟萃，2018, 33(2): 100-102, 110.
|
| [17] |
Pitocco D, Spanu T, Di Leo M, et al. Diabetic foot infections: a comprehensive overview[J]. Eur Rev Med Pharmacol Sci, 2019, 23(2 Suppl): 26-37.
|
| [18] |
Shettigar K, Murali TS. Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection[J]. Eur J Clin Microbiol Infect Dis, 2020, 39(12): 2235-2246.
|
| [19] |
Macdonald KE, Boeckh S, Stacey HJ, et al. The microbiology of diabetic foot infections: a meta-analysis[J]. BMC Infect Dis, 2021, 21(1): 770.
|
| [20] |
Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study[J]. Diabet Med, 2018, 35(1): 78-88.
|
| [21] |
Vriens B, D′Abate F, Ozdemir BA, et al. Clinical examination and non-invasive screening tests in the diagnosis of peripheral artery disease in people with diabetes-related foot ulceration[J]. Diabet Med, 2018, 35(7): 895-902.
|
| [22] |
Forsythe RO, Apelqvist J, Boyko EJ, et al. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review[J]. Diabetes Metab Res Rev, 2020, 36 Suppl 1: e3277.
|
| [23] |
Williams DT, Harding KG, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes[J]. Diabetes Care, 2005, 28(9): 2206-2210.
|
| [24] |
Zilliox LA. Diabetes and Peripheral Nerve Disease[J]. Clin Geriatr Med, 2021, 37(2): 253-267.
|
| [25] |
Wang A, Lv G, Cheng X, et al. Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)[J]. Burns Trauma, 2020, 8: tkaa017.
|
| [26] |
Peters EJ, Lipsky BA. Diagnosis and management of infection in the diabetic foot[J]. Med Clin North Am, 2013, 97(5): 911-946.
|
| [27] |
Park JH, Suh DH, Kim HJ, et al. Role of procalcitonin in infected diabetic foot ulcer[J]. Diabetes Res Clin Pract, 2017, 128: 51-57.
|
| [28] |
Aragón-Sánchez J, Lipsky BA. Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches[J]. Expert Rev Anti Infect Ther, 2018, 16(1): 35-50.
|
| [29] |
Rastogi A, Mukhopadhyay S, Sahoo JP, et al. Intensive Glycemic Control for Diabetic Foot Ulcer Healing: A Multicentric, Randomized, Parallel Arm, Single-Blind, Controlled Study Protocol (INGLOBE Study)[J]. Int J Low Extrem Wounds, 2020: 1534734620952245.
|
| [30] |
冯颖，祝红娟，王倩，等. 糖尿病足患者血糖管理的研究进展[J/CD]. 中华损伤与修复杂志(电子版), 2021, 16(5): 445-448.
|
| [31] |
Yadav C, Srikantiah RM, Manjrekar P, et al. Assessment of Mineral Pathophysiology in Patients with Diabetic Foot Ulcer[J]. Biol Trace Elem Res, 2020, 195(2): 366-372.
|
| [32] |
Choke E, Tang TY, Cheng SC, et al. Treatment of lower limb ischaemia in patients with diabetes[J]. Diabetes Metab Res Rev, 2020, 36 Suppl 1: e3262.
|
| [33] |
徐俊，许樟荣. 国际糖尿病足工作组《糖尿病足溃疡周围动脉病变诊断、预后与管理指南(2019版)》解读[J]. 国际内分泌代谢杂志，2021, 41(2): 142-144.
|
| [34] |
Schaper NC, van Netten JJ, Apelqvist J, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)[J]. Diabetes Metab Res Rev, 2020, 36 Suppl 1: e3266.
|
| [35] |
Nativel M, Potier L, Alexandre L, et al. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review[J]. Cardiovasc Diabetol, 2018, 17(1): 138.
|
| [36] |
Farah S, Yammine K. A systematic review on the efficacy of vitamin B supplementation on diabetic peripheral neuropathy[J]. Nutr Rev, 2022, 80(5): 1340-1355.
|
| [37] |
Stein J, Geisel J, Obeid R. Association between neuropathy and B-vitamins: A systematic review and meta-analysis[J]. Eur J Neurol, 2021, 28(6): 2054-2064.
|
| [38] |
Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy[J]. Nat Rev Endocrinol, 2021, 17(7): 400-420.
|
| [39] |
Lazzarini PA, Jarl G, Gooday C, et al. Effectiveness of offloading interventions to heal foot ulcers in persons with diabetes: a systematic review[J]. Diabetes Metab Res Rev, 2020, 36 Suppl 1(Suppl 1): e3275.
|
| [40] |
Quinton TR, Lazzarini PA, Boyle FM, et al. How do Australian podiatrists manage patients with diabetes? The Australian diabetic foot management survey[J]. J Foot Ankle Res, 2015, 8: 16.
|
| [41] |
Raspovic A, Landorf KB. A survey of offloading practices for diabetes-related plantar neuropathic foot ulcers[J]. J Foot Ankle Res, 2014, 7: 35.
|
| [42] |
Morona JK, Buckley ES, Jones S, et al. Comparison of the clinical effectiveness of different off-loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta-analysis[J]. Diabetes Metab Res Rev, 2013, 29(3): 183-193.
|
| [43] |
Rinkel WD, Franks B, Birnie E, et al. Cost-Effectiveness of Lower Extremity Nerve Decompression Surgery in the Prevention of Ulcers and Amputations: A Markov Analysis[J]. Plast Reconstr Surg, 2021, 148(5): 1135-1145.
|
| [44] |
Dallimore SM, Kaminski MR. Tendon lengthening and fascia release for healing and preventing diabetic foot ulcers: a systematic review and meta-analysis[J]. J Foot Ankle Res, 2015, 8: 33.
|
| [45] |
Kalantar Motamedi A, Ansari M. Comparison of Metatarsal Head Resection Versus Conservative Care in Treatment of Neuropathic Diabetic Foot Ulcers[J]. J Foot Ankle Surg, 2017, 56(3): 428-433.
|
| [46] |
Armstrong DG, Fiorito JL, Leykum BJ, et al. Clinical efficacy of the pan metatarsal head resection as a curative procedure in patients with diabetes mellitus and neuropathic forefoot wounds[J]. Foot Ankle Spec, 2012, 5(4): 235-240.
|
| [47] |
Everett E, Mathioudakis N. Update on management of diabetic foot ulcers[J]. Ann N Y Acad Sci, 2018, 1411(1): 153-165.
|
| [48] |
Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections[J]. Clin Infect Dis, 2012, 54(12): e132-e173.
|
| [49] |
De Francesco F, Graziano A, Trovato L, et al. A Regenerative Approach with Dermal Micrografts in the Treatment of Chronic Ulcers[J]. Stem Cell Rev Rep, 2017, 13(1): 139-148.
|
| [50] |
王知，李恭驰，李炳辉，等. 猪脱细胞真皮基质促进皮肤细胞迁移修复小鼠创面的研究[J]. 中华实验外科杂志，2020, 37(7): 1230-1233.
|
| [51] |
Suthar M, Gupta S, Bukhari S, et al. Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series[J]. J Biomed Sci, 2017, 24(1): 16.
|
| [52] |
陈诺，李羽霖，阮琼芳，等. 浓缩生长因子及其在促进损伤组织修复中的应用进展[J/CD]. 中华损伤与修复杂志(电子版), 2021, 16(6): 520-524.
|
| [53] |
王爱红，许樟荣. 全面系统评估——确保糖尿病足溃疡科学规范诊治的基础[J]. 华西医学，2021, 36(4): 432-435.
|
| [54] |
Paisey RB, Abbott A, Paisey CF, et al. Diabetic foot ulcer incidence and survival with improved diabetic foot services: an 18-year study[J]. Diabet Med, 2019, 36(11): 1424-1430.
|
| [55] |
陈明卫，许樟荣. 糖尿病足病：时代在改变[J]. 中华糖尿病杂志，2020, 12(6): 359-363.
|